Drug-induced QTc interval prolongation: A proposal towards an efficient and safe anticancer drug development
- 31 March 2008
- journal article
- review article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 44 (4), 494-500
- https://doi.org/10.1016/j.ejca.2007.10.001
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Can pharmacogenetics help rescue drugs withdrawn from the market?Pharmacogenomics, 2006
- Drug-Induced Prolongation of the QT IntervalThe New England Journal of Medicine, 2004
- Isolated tissue models and proarrhythmiaEuropean Heart Journal Supplements, 2001
- The Canine Purkinje Fiber: An In Vitro Model System for Acquired Long QT Syndrome and Drug-Induced ArrhythmogenesisJournal of Cardiovascular Pharmacology, 2001
- Problems of Heart Rate Correction in Assessment of Drug‐Induced QT Interval ProlongationJournal of Cardiovascular Electrophysiology, 2001
- The long QT syndromes: genetic basis and clinical implicationsJournal of the American College of Cardiology, 2000
- LONG QT SYNDROMECardiology Clinics, 2000
- Long QT syndromes and torsade de pointesThe Lancet, 1999
- ECG T-Wave Patterns in Genetically Distinct Forms of the Hereditary Long QT SyndromeCirculation, 1995
- Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmiaThe American Journal of Cardiology, 1991